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Urinary microvesicles, such as 40–100nm exosomes and
100–1000nm microparticles, contain many proteins that may
serve as biomarkers of renal disease. Microvesicles have been
isolated by ultracentrifugation or nanomembrane
ultrafiltration from normal urine; however, little is known
about the efficiency of these methods in isolating
microvesicles from patients with nephrotic-range proteinuria.
Here we compared three techniques to isolate microvesicles
from nephrotic urine: nanomembrane ultrafiltration,
ultracentrifugation, and ultracentrifugation followed by size-
exclusion chromatography (UC-SEC). Highly abundant
urinary proteins were still present in sufficient quantity after
ultrafiltration or ultracentrifugation to blunt detection of less
abundant microvesicular proteins by MALDI-TOF-TOF mass
spectrometry. The microvesicular markers neprilysin,
aquaporin-2, and podocalyxin were highly enriched following
UC-SEC compared with preparations by ultrafiltration or
ultracentrifugation alone. Electron microscopy of the UC-SEC
fractions found microvesicles of varying size, compatible with
the presence of both exosomes and microparticles. Thus,
UC-SEC following ultracentrifugation to further enrich and
purify microparticles facilitates the search for prognostic
biomarkers that might be used to predict the clinical course
of nephrotic syndrome.
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Urine is an ideal biological sample for the discovery of new
biomarkers because of the ease and noninvasive nature of
collection. In addition to soluble plasma proteins, urine also
contains microvesicles such as exosomes and microparticles
that may constitute a rich source of intracellular renal
biomarkers.1–3 Urinary exosomes are membrane vesicles with
a diameter of 40–100 nm secreted by tubular cells and
podocytes.2,4 They are formed by fusion of endosomes with
the outer membrane of multivesicular bodies (MVBs) and
subsequent internalization into the MVB by membrane
invagination.2 When MVB fuse with the apical membrane,
the internal vesicles enter the tubular lumen as exosomes.5 In
contrast, microparticles are membrane-shed vesicles with a
size range between 100 and 1000 nm.3 Microvesicles not only
contain membrane-bound proteins, but their lumina also
contain cytosolic proteins that become trapped during
invagination into the MVB or budding from the plasma
membrane.6 Microparticles can be released by a variety of
conditions, including cell activation, oxidative stress, and
apoptosis.7
The formation and excretion of microvesicles is theorized
to take place in every segment of the renal tubulus. Thus,
analysis of microvesicles should provide information about
the pathophysiological state of the entire renal tubule.2,4
Recent studies have shown that microvesicles can be
recovered from urine by ultracentrifugation or ultrafiltration
techniques.1,2,8 However, these studies focused predomi-
nantly on patients with normal urine. Little is known about
the efficiency of these methods in isolating microvesicles
from patients with nephrotic-range proteinuria. Nephrotic
urine contains a large amount of highly abundant proteins
that tend to be retained by ultrafiltration and to a lesser
extent also by ultracentrifugation.4 These highly abundant
proteins interfere with microvesicular protein identification
by proteomic techniques and complicate the search for
prognostic biomarkers that might be used to predict the
clinical course of the nephrotic syndrome. In this study, we
have performed a comparison of different methods to isolate
microvesicles from urine of patients with a nephrotic
syndrome.
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RESULTS
Isolation of microvesicles by ultracentrifugation and
nanomembrane ultrafiltration
Isolation of microvesicular proteins from nephrotic urine
using the ultracentrifugation or the ultrafiltration method
proved to be very difficult (Figure 1). Highly abundant
proteins, especially albumin and a-1-antitrypsin, were
present in large amounts after ultracentrifugation or
nanomembrane ultrafiltration. These highly abundant pro-
teins limited the detection of microvesicular proteins
(Supplementary Table S1). Only two large membrane-
associated proteins, aminopeptidase N and nebulin, could
be identified after ultracentrifugation (Supplementary
Table S1). We observed a similar interference with micro-
vesicular protein detection after ultracentrifugation of urine
from a healthy volunteer with 0.4 or 1% bovine serum
albumin added. Addition of this resulted in extra bands at 73
and 150 kDa, compatible with albumin, and disappearance
of the lower molecular weight (LMW) bands (Figure 2).
These observations strongly suggested that coprecipitation
of highly abundant proteins with microvesicles into the
pellet interfered with the identification of microvesicular
proteins.
Isolation of microvesicles by ultracentrifugation followed
by SEC
To separate highly abundant proteins from microvesicles,
pellets obtained by ultracentrifugation were loaded onto a
size-exclusion column. The chromatograms after size-exclu-
sion chromatography (SEC) of nephrotic urine showed three
fractions: (1) a high molecular weight (HMW) fraction
corresponding to a molecular weight 4670 kDa; (2) a LMW
fraction corresponding to a molecular weight 10–670 kDa;
and (3) a third fraction corresponding to a molecular weight
o10 kDa (Figure 3). For proteomic analysis, the HMW
fraction was resolved by one-dimensional SDS polyacryla-
mide gel electrophoresis (Figure 4a). Matrix-assisted laser
desorption/ionization-time of flight-time of flight analysis
(MALDI-TOF-TOF) of the HMW fraction identified proteins
known to be present in microvesicles, including membrane-
associated proteins (annexin A2/A5, aminopeptidase N,
angiotensin-converting enzyme 2, aquaporin-1), extracellular
proteins (vitronectin and clusterin), and galectin-3-binding
protein, a protein involved in cell adhesion and a potent
immune stimulator (Supplementary Table S2). In contrast,
the LMW fraction only contained highly abundant proteins,
but no microvesicular proteins (Figure 4b; Supplementary
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Figure 1 |One-dimensional gel electrophoresis showing the
difficulty of isolating microvesicular proteins from nephrotic
syndrome. Isolation by (a) the nanomembrane concentrator.
Lane 1, retentate; lane 2, proteins remaining on the
nanomembrane after the retentate was removed and washed
with Laemmli buffer; and (b) the ultracentrifugation method. The
abundant protein at 73 kDa was identified as albumin. Spot
numbers refer to the numbers in Supplementary Table S1, where
mass spectrometric data are presented. The urine sample was
obtained from a patient with membranous nephropathy (protein
concentration of 3.7 g/l; protein excretion 5.2 g per 24 h).
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Figure 2 |One-dimensional gel electrophoresis of urine from a
normal control showing coprecipitation of albumin with
exosomes after ultracentrifugation. Lane 1, normal urine; lane 2,
normal urine with 0.4% bovine serum albumin (BSA) added;
lane 3, normal urine with 1% BSA. Ultracentrifugation of urine
with nephrotic-range concentrations of albumin resulted in
coprecipitation of albumin (lanes 2 and 3 at 73 and 150 kDa,
respectively) with the exosomes.
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Table S2). Of note, the LMW fraction was only present in
urine from patients with nephrotic syndrome and was not
observed in normal urine (Figure 3). Electron microscopy
verified the presence of urinary microvesicles (Figure 5) in
the HMW fraction. Quantitative analysis of electron micro-
graphs of urinary microvesicles revealed that the size of these
vesicles varied between 50 and 300 nm, compatible with both
exosomes and microparticles.
Comparison of isolation methods by western blot analysis
We then compared the three methods for their ability to enrich
for typical microvesicular proteins (aquaporin-2 (AQP2) and
neprilysin) and depleting high abundant proteins (albumin)
from nephrotic urine. Both AQP2 and neprilysin could be
detected by western blot analysis (Figure 6) in the HMW
fraction obtained after ultracentrifugation followed by SEC
(UC-SEC), but not in the LMW fraction. In contrast, the
HMW fraction contained lower amounts of albumin in
comparison to the LMW fraction. Microvesicular markers
were not detectable using ultrafiltration. A small neprilysin
band was detectable using ultracentrifugation. Clearly, albu-
min was more abundant in samples obtained by ultracen-
trifugation or ultrafiltration (Figure 6).
Effect of DTT on removal of highly abundant proteins
To investigate the effect of dithiothreitol (DTT) on depletion
of highly abundant proteins (albumin), we compared
UC-SEC to ultracentrifugation followed by resuspension
of the pellet in DTT. The HMW fraction obtained after
UC-SEC still contained lower amounts of albumin in
comparison to ultracentrifugation with DTT (Figure 7).
Moreover, compared with ultracentrifugation with DTT,
UC-SEC resulted in an enrichment of the podocytic marker
podocalyxin (PODXL; Figure 7).
DISCUSSION
Urinary biomarkers can be derived from different protein
sources, including soluble proteins, sediment proteins, and
microvesicles.5 It would be beneficial if candidate surrogate
biomarkers for renal disease were not simply filtered serum
proteins but rather cell-derived proteins that were involved in
the disease pathogenesis or progression. To explore the
different urinary proteomes, efficient isolation of fraction
such as microvesicles requires minimal contamination by
soluble proteins or sediment proteins for sensitive biomarker
discovery. Previous studies demonstrated that ultracentrifu-
gation and nanomembrane ultrafiltration can effectively
isolate microvesicles, largely consisting of exosomes, from
normal urine.2,8 However, our study shows that isolation of
microvesicles from nephrotic urine, by these established
isolation methods, is limited due to interference by highly
abundant soluble proteins. We noted that the large amount
of protein present in nephrotic urine obstructed the
nanomembrane during ultrafiltration. As a result, ultrafiltra-
tion efficiency was significantly reduced and soluble proteins
were retained by the nanomembrane concentrator. Similarly,
highly abundant soluble proteins were also present in large
amounts in the microvesicular pellet after ultracentrifugation
(Figure 1). Ultracentrifugation of normal urine with bovine
serum albumin added in concentrations comparable to
nephrotic urine showed that soluble proteins, not present
in microvesicles (nonmicrovesicular proteins), can become
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Figure 3 |Chromatogram obtained after size-exclusion chromatography. Chromatogram of (a) urine sample from a patient with
membranous nephropathy (protein concentration 10.6 g/l; protein excretion 17.7 g per 24 h). (b) Urine sample from a patient with focal
segmental glomerulosclerosis (protein concentration 7.3 g/l; protein excretion 7.2 g per 24 h). (c) Urine sample from a normal control. A
lower molecular weight fraction with a retention time of 8–12min (a) or 9–12min (b) is present in the urine obtained from patients with
nephrotic-range proteinuria.
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entrapped into the pellet and limit the identification of lower
abundant microvesicular proteins (Figure 2). The exact
mechanism resulting in entrapment of nonmicrovesicular
proteins is not known. Soluble proteins could coprecipitate
through specific or nonspecific mechanisms with micro-
vesicles into the pellet. Indeed, highly abundant soluble
proteins could also originate from within the microvesicles.
Filtered proteins are reabsorbed along the entire nephron and
accumulate in the cytoplasm of tubular cells. During their
formation, microvesicles can incorporate these cytoplasmic
soluble proteins in their lumina. Therefore, methods such as
the one presented herein, which maintain the microvesicular
structure and minimize the copurification of highly abun-
dant nonmicrovesicular proteins, are vital to significantly
improve detection of microvesicular proteins.
In dealing with complex protein samples, most of the
current proteomic analysis methods are still limited with
respect to their dynamic range and sensitivity.9 One approach
to enhanced detection and identification of microvesicular
proteins is through use of the state-of-the-art mass spectro-
metric methods such as those demonstrated by Pisitkun and
Gonzales.2,10 A second approach to enhanced detection
includes methods that also specifically reduce copurification
of highly abundant proteins from urine samples. These
methods would then also improve the ability of mass
spectrometry approach to detect lower abundant proteins.11
In this study, we demonstrate through enrichment of marker
proteins neprilysin, AQP2, and PODXL that the existing
ultracentrifugation method for urinary microvesicle isolation
can be improved by application of SEC (Figures 6 and 7). The
presented UC-SEC method also allowed for detection of
microvesicular proteins such as membrane-associated pro-
teins, antiapoptosis, and extracellular matrix proteins. It is
our expectation that incorporation of this method ahead of
direct analysis by liquid chromatography mass spectro-
photometry methods would yield a more exhaustive list of
known and possibly previously unrecognized microvesicular
proteins that have not been described in normal urine.
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Figure 4 |One-dimensional gel electrophoresis of proteins
isolated by ultracentrifugation followed by size-exclusion
chromatography. (a) High molecular weight fraction (retention
time 5–8min). (b) Lower molecular weight fraction (retention time
8–10min). Spot numbers refer to the numbers in Supplementary
Table S2, where mass spectrometric data are presented. The urine
sample was obtained from a patient with idiopathic membranous
nephropathy (protein concentration 10.6 g/l; protein excretion
17.7 g per 24 h).
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Figure 5 | Electron microscopic image of urinary microvesicles. Urinary microvesicles were obtained by ultracentrifugation followed
by size-exclusion chromatography. (a) Sample from a patient with idiopathic membranous nephropathy (protein concentration 4.4 g/l;
protein excretion 7.5 g per 24 h). (b) Sample from a patient with focal segmental glomerulosclerosis (protein concentration 6.0 g/l;
protein excretion 19.4 g per 24 h).
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To optimize the identification of exosomal proteins in
normal urine, earlier studies used DTT to remove the
high abundant protein Tamm–Horsfall protein (THP)
from exosomes obtained from the high-speed pellet at
200,000 g.2,10 DTT denatures the zona pellucida domains in
the THP, thus inhibiting aggregation and entrapment of
exosomes by polymeric THP networks and removal of THP
in the UC sample supernatant. Theoretically, highly abun-
dant proteins could also become entrapped in the polymeric
THP network containing microvesicles. We performed an
immunoblot analysis after reduction of the 200,000 g pellet
with DTT and reultracentrifugation. A direct comparison of
the UC-SEC method with the ultracentrifugation with DTT
reduction step showed that the UC-SEC approach is more
efficient in the removal of albumin and enrichment for the
microvesicular protein PODXL (Figure 7).
Recently, it was demonstrated that exosomes in normal urine
can become entrapped in the polymeric THP networks present
in the low-speed 17,000 g pellet.12 The yield of exosomes was
increased by addition of DTT to the low-speed pellet at
17,000 g. This modification resulted in a more complete
retrieval of exosomes in the high-speed pellet of normal urine.
To achieve a more complete retrieval of microvesicles from
nephrotic urine, addition of DTT to the 17,000 g pellet can serve
as a useful extension of our UC-SEC method.
On initial analysis, our data appear to differ with previous
studies reporting successful identification of potential
microvesicular biomarkers in nephrotic urine using ultra-
filtration and ultracentrifugation. Cheruvanky et al.8 isolated
exosomes using the nanomembrane ultrafiltration method.
They were able to identify PODXL in urine from patients
with focal segmental glomerulosclerosis and nephrotic-range
proteinuria by western blot analysis. In a second study, the
same group used the ultracentrifugation method to detect a
transcription factor, Wilms Tumor 1, in nephrotic urine from
patients with focal segmental glomerulosclerosis.13 Still, we
do not believe that our results contradict those of previous
studies. In agreement with our findings, Gonzales et al. also
report that ultrafiltration tends to retain and concentrate
soluble proteins in urine in addition to exosomes, reducing
the sensitivity of the discovery process.4,8 This study also
shows that western blot analysis can identify microvesicular
proteins, such as neprilysin and PODXL, in nephrotic urine
using ultracentrifugation. However, our study shows that
highly abundant soluble proteins can interfere with detection
of microvesicular proteins as reflected by the significantly
smaller neprilysin and PODXL band detected after ultra-
centrifugation in comparison with UC-SEC and the absent
AQP2 band after ultracentrifugation. Therefore, the differ-
ence between previous studies and our study most likely
reflects differences in the abundance of microvesicular
proteins. If present in high concentrations, microvesicular
proteins can still be detected by western blot analysis using
ultracentrifugation and ultrafiltration, despite interference by
highly abundant soluble proteins. In contrast, lower abun-
dant microvesicular proteins are not detected in nephrotic
urine by these isolation methods.
In normal urine, many of the microvesicles were extremely
small.2 Electron micrographic images of nephrotic samples
revealed microvesicles that varied in size. A substantial part of
these microvesicles was 4100 nm. In addition to exosomes,
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Figure 6 | Efficiency of urinary microvesicle isolation by
ultracentrifugation (lane 1), nanomembrane ultrafiltration
(lane 2), ultracentrifugation followed by size-exclusion
chromatography (high molecular weight fraction, lane 3), and
ultracentrifugation followed by size-exclusion
chromatography (lower molecular weight fraction, lane 4).
Western blot analysis was performed for neprilysin, aquaporin-2,
and albumin. (a) Urine sample from a patient with idiopathic
membranous nephropathy (protein concentration 4.4 g/l; protein
excretion 7.5 g per 24 h). (b) Urine sample from a patient with
focal segmental glomerulosclerosis (protein concentration 6.0 g/l;
protein excretion 19.4 g per 24 h).
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Figure 7 | Efficiency of urinary microvesicle isolation by
ultracentrifugation followed by size-exclusion
chromatography (high molecular weight fraction, lane 1),
ultracentrifugation followed by removal of Tamm–Horsfall
protein from the 200,000 g pellet with dithiothreitol (DTT)
and reultracentrifugation (lane 2). Western blot analysis was
performed for podocalyxin and albumin. Pooled urine sample
from three patients with idiopathic membranous nephropathy
(median protein concentration 4.6 (range 3.1–4.6) g/l; median
protein excretion 5.0 (3.5–6.3) g per 24 h).
814 Kidney International (2010) 78, 810–816
t echn i ca l no tes IM Rood et al.: Isolation of microvesicles from nephrotic urine
cells can also release other forms of membrane vesicles in the
extracellular environment. These vesicles are larger than
exosomes and are often referred to as microparticles
(100–1000 nm). These microparticles bud directly from the
plasma/apical cell membrane after stress, activation, or
apoptosis.3,14 The formation of microparticles can be
stimulated by inflammatory stimuli including cytokines or
activated complement.15 Both in human proteinuric disease
and in experimental models evidence of complement
activation can be detected on the apical surface of the renal
tubular cells.16–18 Similarly, protein components can stimu-
late tubular cells to secrete a large number of cytokines.19,20
Thus, stimulation of tubular complement and cytokine
production by proteins could explain the presence of
microparticles in nephrotic urine.
In conclusion, we present a method that improved the
isolation of microvesicles from nephrotic urine. Although
UC-SEC is more time consuming compared with ultracen-
trifugation or ultrafiltration, this method allows for identi-
fication of lower abundant microvesicular proteins in
nephrotic urine without interference by highly abundant
proteins. These improvements in microvesicular isolation
should facilitate the identification of biomarkers in renal
diseases associated with a nephrotic syndrome.
MATERIALS AND METHODS
A full description of the methods is provided in the Supplementary
information.
Urine collection and storage
Urine samples from patients with idiopathic membranous nephro-
pathy and focal segmental glomerulosclerosis were collected at the
Radboud University Nijmegen Medical Center. These patients had a
nephrotic syndrome defined as proteinuria 43 g per 24 h and serum
albumin o3.0 g/dl. Urine samples from healthy volunteers were
collected at the University of Louisville. Collection and storage was
performed as described by Zhou et al.21
Sample preparation and isolation methods
Urine samples (45 ml) were extensively vortexed immediately after
thawing.21 Thawed samples were filtrated through chromatography
paper followed by differential centrifugation at 17,000 g for 15 min at
4 1C to remove urinary sediment. Three different methods to isolate
microvesicles from the 17,000 g supernatant were evaluated.2,8 (1) Ultra-
centrifugation: The 17,000 g supernatant was centrifuged at 200,000 g
for 110 min at 4 1C. The resulting pellet was resuspended in 50ml of
isolation solution (250 mM sucrose per 10 mM triethanolamine).2 In one
of the collected urine samples, the resuspended pellet was incubated
with the reducing agent DTT and the ultracentrifugation was repeated
as above. (2) Nanomembrane ultrafiltration concentrator: The 17,000 g
supernatant was diluted to 0.5 g/l to reduce obstruction of the nano-
membrane by highly abundant proteins and added to Vivaspin 20
polyethersulfone nanomembrane concentrators (Sartorius, Goettingen,
Germany) (molecular weight cut-off 100 kDa) to collect the micro-
vesicles.8 After centrifugation of urine at 3000 g, the retentate was
removed from the concentrator and an equal volume of preheated 2
Laemmli buffer was added. The nanomembrane was subsequently
washed to remove remaining proteins that adhered to the membrane
by adding two volumes of preheated 1 Laemmli buffer with 10%
b-mercaptoethanol into the concentrator and shaking the concen-
trator at room temperature. (3) Ultracentrifugation followed by SEC:
Ultracentrifugation was performed as described under (1). The
resulting pellet was resuspended in phosphate-buffered saline to
obtain intact microvesicles. The sample was loaded onto an SEC
column. Fractions of 1 ml were collected. On the basis of the
chromatogram, fractions were combined to obtain a HMW and a
low molecular weight fraction. Both fractions were concentrated by
centrifugation at 3000 g using Amicon Ultra-4 (Millipore, Billerica,
MA, USA) (10 kDa molecular weight cut-off). The retentate was
removed from the concentrator and 1% octyl b-D-glucopyranoside was
added to strip the membrane of proteins adhered to the nanomem-
brane.8 A micro bicinchoninic acid-protein assay was performed on all
samples to determine the protein concentration.
One-dimensional gel electrophoresis and western blotting
Equal amounts of protein obtained using methods 1–3 were
separated by one-dimensional SDS polyaclylamide gel electrophoresis.
For western blot analysis, proteins were electrophoretically
transferred from one-dimensional SDS polyaclylamide gel electro-
phoresis to nitrocellulose membranes, which were blocked and
probed with antigen-specific primary antibodies (as described in
supporting methods). Horseradish peroxidase-conjugated secondary
antibodies were used. Signals were developed using a luminol-based
chemiluminescence reagent.
In-gel trypsin digestion and MALDI-TOF-TOF mass
spectrometry
Samples were prepared using a modification of the technique
described by Jensen et al.22 The protein spots were excised from the
stained gels. After destaining, proteins in the gel were reduced,
alkylated, and trypsinized as described in the supporting methods.
The trypsin digest was pipetted directly onto the stainless steel
sample plate of the mass spectrometer. Mass spectral data were
obtained using a MALDI-TOF-TOF instrument (AB4700 protein
analyzer, Applied Biosystems, Foster City, CA, USA). Data were
analyzed using Mascot 2.1 against the 20051115/20061212 Swiss
Protein database. A Mascot score of X56 was considered to be
statistically significant (Po0.05).
Transmission electron microscopy
Isolated microvesicles were prepared as described in the Supple-
mentary methods and mounted on 200-mesh copper grids, stained
with uranyl acetate and lead citrate, and viewed in a Philips
(Eindhoven, The Netherlands) CM12 transmission electron micro-
scope operating at 60 KV.
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